Market Overview

Why Allscripts Healthcare's Stock Is Trading Lower Today

Share:
Why Allscripts Healthcare's Stock Is Trading Lower Today

Allscripts Healthcare Solutions (NASDAQ: MDRX) shares are trading lower on Tuesday after Goldman Sachs downgraded the stock from Neutral to Sell and lowered its price target from $6.50 to $5.50 per share.

Allscripts Healthcare Solutions provides information technology and offerings to acute and ambulatory providers as well as hospital services. The company supports electric medical records, private cloud hosting, and other clinical services that support patient engagement and better outcomes.

Additionally, the company offers administrative tools and services to improve operations, such as practice management, revenue cycle management, and clinical care coordination. Allscripts was founded in 1986 and is headquartered in Chicago.

Allscripts Healthcare shares were trading down 9.42% at $6.54 during the time of publication on Tuesday. The stock has a 52-week high of $11.82 and a 52-week low of $4.56.

Latest Ratings for MDRX

DateFirmActionFromTo
Nov 2020B of A SecuritiesMaintainsBuy
Oct 2020BairdDowngradesOutperformNeutral
Oct 2020Cantor FitzgeraldMaintainsNeutral

View More Analyst Ratings for MDRX
View the Latest Analyst Ratings

 

Related Articles (MDRX)

View Comments and Join the Discussion!

Posted-In: why it's movingDowngrades Price Target Analyst Ratings

Latest Ratings

StockFirmActionPT
DISCitigroupMaintains175.0
AYLANoble Capital MarketsInitiates Coverage On29.0
SHOPSusquehannaInitiates Coverage On950.0
SICraig-HallumInitiates Coverage On50.0
WORKStephens & Co.Downgrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com